The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.

Saved in:
Bibliographic Details
Title: The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.
Authors: Scarisbrick JJ; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K.; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Member of the UK Cutaneous Lymphoma Group., Quaglino P; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Prince HM; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Papadavid E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Hodak E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Bagot M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Servitje O; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Berti E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Ortiz-Romero P; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Stadler R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Patsatsi A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Knobler R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Guenova E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Child F; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the UK Cutaneous Lymphoma Group., Whittaker S; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Member of the UK Cutaneous Lymphoma Group., Nikolaou V; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Tomasini C; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Amitay I; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Prag Naveh H; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Ram-Wolff C; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Battistella M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Alberti-Violetti S; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Stranzenbach R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Gargallo V; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Muniesa C; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Koletsa T; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Jonak C; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Porkert S; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Mitteldorf C; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Estrach T; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Combalia A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Marschalko M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Csomor J; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Szepesi A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Cozzio A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Dummer R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Pimpinelli N; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Grandi V; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Beylot-Barry M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Pham-Ledard A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Wobser M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Geissinger E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Wehkamp U; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Weichenthal M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Cowan R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the UK Cutaneous Lymphoma Group., Parry E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the UK Cutaneous Lymphoma Group., Harris J; Member of the UK Cutaneous Lymphoma Group., Wachsmuth R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the UK Cutaneous Lymphoma Group., Turner D; Member of the UK Cutaneous Lymphoma Group., Bates A; Member of the UK Cutaneous Lymphoma Group., Healy E; Member of the UK Cutaneous Lymphoma Group., Trautinger F; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Latzka J; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Yoo J; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K.; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Vydianath B; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K., Amel-Kashipaz R; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K., Marinos L; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Oikonomidi A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Stratigos A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Vignon-Pennamen MD; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Battistella M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Climent F; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Gonzalez-Barca E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Georgiou E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Senetta R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Zinzani P; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Vakeva L; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Ranki A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Busschots AM; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Hauben E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Bervoets A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Woei-A-Jin FJSH; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Matin R; Member of the UK Cutaneous Lymphoma Group., Collins G; Member of the UK Cutaneous Lymphoma Group., Weatherhead S; Member of the UK Cutaneous Lymphoma Group., Frew J; Member of the UK Cutaneous Lymphoma Group., Bayne M; Member of the UK Cutaneous Lymphoma Group., Dunnill G; Member of the UK Cutaneous Lymphoma Group., McKay P; Member of the UK Cutaneous Lymphoma Group., Arumainathan A; Member of the UK Cutaneous Lymphoma Group., Azurdia R; Member of the UK Cutaneous Lymphoma Group., Benstead K; Member of the UK Cutaneous Lymphoma Group., Twigger R; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Rieger K; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Brown R; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Sanches JA; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Miyashiro D; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Akilov O; Member of the Cutaneous Lymphoma International Consortium (CLIC)., McCann S; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Sahi H; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Damasco FM; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Querfeld C; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Folkes A; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Bur C; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Klemke CD; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Enz P; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Pujol R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Quint K; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Geskin L; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Hong E; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Evison F; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K., Vermeer M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Cerroni L; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Kempf W; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Kim Y; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Willemze R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.
Source: The British journal of dermatology [Br J Dermatol] 2019 Aug; Vol. 181 (2), pp. 350-357. Date of Electronic Publication: 2018 Nov 25.
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1365-2133
DOI:10.1111/bjd.17258